OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: The University of Edinburgh

3 Projects | 2 Researchers | $835,570 Invested

2025

The University of Edinburgh

Neil McKenzie, PhD, CChem, MSc, BSc(Hons)

“The development and evaluation of a clinical RT-QuIC test for diagnosis of TDP-43 linked Fronto-temporal dementias: A small multicentre trial.”

  • Funding Amount: $144,585
  • Organization Type:
  • Program: Biomarkers
  • Target: Proteostasis/Proteinopathies
  • Status: Active

2022

The University of Edinburgh

Neil McKenzie, PhD, CChem, MSc, BSc(Hons)

The development and evaluation of a clinical RT-QuIC test for diagnosis of TDP-43 linked Fronto-temporal dementias

  • Funding Amount: $201,988
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Proteostasis/Proteinopathies
  • Status: Active

2019

The University of Edinburgh

Tom MacGillivray, BSc, MSc, PhD

Delivering novel neuro-retinal biomarkers for the early diagnosis of Alzheimer’s disease

  • Funding Amount: $488,997
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Target: Other
  • Status: Closed